Sylvia Daunert's picture

Sylvia Daunert

Gill Eminent Professor of Analytical and Biological Chemistry

Professor of Chemistry
Professor of Pharmaceutical Sciences
Biological and Bioanalytical Chemistry 

Editor, Analytical and Bioanalytical Chemistry


Office: 219 Chemistry-Physics Building
Phone: (859) 257-7060
FAX: (859) 323-1069
Email: daunert@pop.uky.edu
 

  • 1982 Pharm. D., University of Barcelona 
  • 1985  MS, Medicinal Chemistry, University of Michigan 
  • 1991 Ph.D., BioAnalytical Chemistry, University of Barcelona 
 
 
 

AWARDS AND DISTINCTIONS

  • Gill Eminent Professor of Analytical and Bioanalytical Chemistry, 2002.
  • Special Creativity Award, National Science Foundation, 2002 
  • A. F. Findeis Award, Division of Analytical Chemistry, American Chemical Society, 2001 
  • Lilly Award in Analytical Chemistry, 1997-1998. 
  • Cottrell Scholar Award, Research Corporation, 1997. 
  • National Science Foundation-CAREER Award, 1995. 
  • The Van Slyke Society Research Award, American Association for Clinical Chemistry, 1992. 
  • Juan Abelló Pascual Award in Biochemistry, Spanish Royal Academy of Doctors, 1992. 
  • Summa Cum Laude, Ph.D. Dissertation, University of Barcelona, Barcelona, Spain, 1991. 
  • Fulbright Scholar, 1983-1985. 

In our group we are interested in using recombinant DNA technology to develop new bioanalytical techniques. A few examples of research projectsthat are currently active within our group are outlined below.

Chemiluminescence assays are ideal for the detection of low levels of biomolecules. In contrast to other sensitive techniques like fluorescence, chemiluminescence and bioluminescence are unaffected by the background fluorescence signal of biological samples. However, the presently used chemiluminescent labels are not ideally suited for use at physiological pH. The use of bioluminescent photoproteins, such as aequorin, as labels can circumvent this limitation of conventional chemiluminescence assays. Aequorin is a calcium-activated photoprotein found in Aequorea victoria (jellyfish), and it can be used as a biological Ca2+ indicator. In our laboratory we use aequorin as a bioluminescent label in the developmentof novel competitive binding assays for biomolecules by taking advantage of the selective interaction between biological binders (antibodies, bindingproteins, receptors, etc.) and ligands. Aequorin-ligand conjugates are prepared by genetic engineering of aequorin. Recently, we have demonstrated that aequorin can be detected at attomole levels. Moreover, we were able to detect 4 attomol of biotin (vitamin H) by using aequorin as a label in a homogeneous competitive binding assay. It is anticipated that extremely sensitive assays for other biologically important molecules (such as neuropeptides, hormones, drugs, etc.) will result from these investigations.

We are also interested in employing aequorin to develop assays for biologically important molecules in single cells. It is well established that understanding the effect of chemical and biochemical compounds on different cells is important in a variety of fields (pharmacology, drug design, toxicology, etc.) In addition, the discovery and study of inherent differences in the composition of morphologically identical cells could help elucidate the correlation between a certain cell behavior observed in diseases and the presence of certain biomolecular species within a cellular subclass. Because the composition of cells varies within a given population, conventional biochemical analyses that measure the average of thousands, if not millions, of cells cannot provide this information. Therefore, there is a need for bioanalytical procedures capable of monitoring the biochemical composition of single cells. The levels of most biomolecules in a given single cell are in the femtomole to attomole range. Consequently, the challenge now lies in determining ultra-low levels of important biomolecules in the small volume of a single cell.

Another area of research in our group focuses in the development of fiber optic sensors for the determination of anions and heavy metal pollutants. Along those lines, bacterial-based fiber optic biosensors are developed that can be used in direct and in in-situ environmental monitoring. The sensors incorporate genetically designed bacterial systems that are engineered to bioluminesce only when a targeted heavy metal pollutant is present. These systems are based on the induction of luciferase-based luminescence. Finally, fiber optic biosensors for anions are being designed by using periplasmic binding proteins as the sensing element. It is well established that periplasmic binding proteins undergo a conformational change upon binding, closing around their corresponding ligand anion. This happens by bending around a hinge between the two globular domains of the protein by a mechanism that resembles that of the venus fly-trap. We take advantage of the conformational change to develop fiber optic sensors for anions of interest.

Sylvia Daunert's Research Group

Group members only